Since human bone metastasis from ductal breast carcinoma shows E-cadherin expression [24], an heterotypic interaction with osteogenic cells would occur, as reported in a human/mouse experimental system, giving a proliferative advantage [18]. The gene discussed is CDH1; the disease is breast ductal adenocarcinoma.